Home / Communication / News

Pharmaceutical process technology and IP: is "out-of-the-box" thinking enough to drive your business forward?

With pharma’s portfolio shifting substantially toward new product types and personalized treatments, pharmaceutical process technology needs to overcome multiple challenges in the course of the supply chain. Competition is fierce and the need for new and revolutionary solutions for drug development starts as early as the selection of the optimal route of synthesis and starting material, often calling for “out-of-the-box” thinking.

Breakthrough solutions, as small as they may be, can drive your business forward. Nevertheless, if you have not considered the intellectual property (IP) landscape, then, you have only developed half a solution, which can drive your business right into the ground.

So, how can you make sure you are making the right decision for your business? You’d better ask an expert.

Analyze the IP landscape & define the right IP strategy for your business

Proper evaluation of the relevant IP landscape is crucial if you wish to be one step ahead of your competitors.

Whether you are considering to create IP assets for your business or not, in today’s era of abundant knowledge and technological advancements, where businesses grow across borders and continents, the intangible assets of human intellectuality cannot be underestimated.

Analyzing the IP landscape will give you a competitive advantage to avoid roadblocks and see hidden opportunities. It will also draw your attention to issues that require frequent monitoring and, why not, lead to an unforeseeable opportunity for the near future, upon change of facts.

Just think of the multiple questions you are faced with when you are about to design, develop and manufacture a new product:

  • Are there any IP restrictions related to the specific product or activity you are planning to commercialize?
  • If there is room for innovation, can you create an IP asset and use it to become competitive?
  • How can you overcome any IP restrictions?
  • Are there any possible IP rights (IPRs) that a competitor might obtain? And how can you work your way around them?
  • And, last but not least, how can you ensure that you won’t stumble upon any legal bottlenecks if you plan to manufacture or commercialize your product in a country other than in Europe?
Protect your product with VIO Chemicals IP solutions

At VIO Chemicals, we have designed our IP solutions to mitigate unnecessary business risks and place your product in a protective environment. Through our local presence and networks into the world’s biggest markets, we can provide complementary or independent IP intelligence, legal and technical support in patent filing and prosecution in Europe, China and India. Our experts have excellent knowledge of the individual patent systems, with a strong focus on the European Patent one, and solid experience in process development for the chemical and pharmaceutical industries. We have our own IP portfolio and use IP strategically, which gives us greater corporate flexibility and increased market value of our products. Last but not least, we respect other companies’ IP rights and ensure that our developments do not infringe on existing patents. To view the full range of our IP solutions, click here.